Vanguard Personalized Indexing Management LLC Grows Holdings in Zoetis Inc. $ZTS

Key Points

• Vanguard Personalized Indexing Management LLC increased its holdings in Zoetis Inc. by 23.9%, owning 69,325 shares valued at approximately $10.82 million.
• Research analysts have given mixed ratings on Zoetis, with price targets ranging from $155 to $215, leading to a consensus rating of "Hold" and an average target price of $196.71.
• Zoetis recently announced a quarterly dividend of $0.50 per share, reflecting a 1.4% yield, with the ex-dividend date set for October 31st.

Vanguard Personalized Indexing Management LLC raised its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 23.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 69,325 shares of the company's stock after buying an additional 13,368 shares during the period. Vanguard Personalized Indexing Management LLC's holdings in Zoetis were worth $10,819,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Nova Wealth Management Inc. purchased a new position in Zoetis in the first quarter valued at $25,000. 1248 Management LLC purchased a new position in Zoetis in the first quarter valued at $27,000. Saudi Central Bank purchased a new position in Zoetis in the first quarter valued at $29,000. REAP Financial Group LLC increased its holdings in Zoetis by 201.5% in the second quarter. REAP Financial Group LLC now owns 196 shares of the company's stock valued at $31,000 after buying an additional 131 shares in the last quarter. Finally, Cornerstone Planning Group LLC increased its holdings in Zoetis by 79.3% in the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock valued at $30,000 after buying an additional 88 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on ZTS shares. Piper Sandler lifted their price objective on shares of Zoetis from $210.00 to $215.00 and gave the company an "overweight" rating in a report on Monday, August 11th. Weiss Ratings reissued a "hold (c-)" rating on shares of Zoetis in a research note on Wednesday, October 8th. Stifel Nicolaus cut shares of Zoetis from a "buy" rating to a "hold" rating and cut their target price for the stock from $165.00 to $160.00 in a research note on Wednesday, June 18th. Leerink Partners cut shares of Zoetis from an "outperform" rating to a "market perform" rating and cut their target price for the stock from $180.00 to $155.00 in a research note on Thursday, July 17th. Finally, Argus reissued a "buy" rating and set a $190.00 target price on shares of Zoetis in a research note on Tuesday, September 9th. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Zoetis presently has a consensus rating of "Hold" and an average target price of $196.71.

Zoetis Stock Down 1.6%

Shares of NYSE ZTS opened at $141.05 on Monday. Zoetis Inc. has a 12-month low of $139.34 and a 12-month high of $196.55. The stock has a market cap of $62.51 billion, a PE ratio of 24.28, a P/E/G ratio of 2.26 and a beta of 0.90. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The company has a 50-day moving average of $149.24 and a 200 day moving average of $154.33.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company had revenue of $2.46 billion during the quarter, compared to analysts' expectations of $2.41 billion. During the same quarter in the prior year, the company earned $1.56 EPS. Zoetis's revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis's dividend payout ratio is currently 34.42%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.